No Data
The Recent HK$3.2b Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Fangzhou Inc. (HKG:6086)
Express News | Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
Express News | Fangzhou Inc - Shares of Co Selected for Inclusion in Hang Seng Hong Kong-Listed Biotech Index From Dec 9
Express News | Fangzhou Inc - Revenue Increased by 2.5% to RMB1,322.8 Mln for Six Months
Fangzhou Shares Down 43% in Pre-Market Session on HK Debut
No Data